1
|
Seldeslachts A, Maurstad MF, Øyen JP, Undheim EAB, Peigneur S, Tytgat J. Exploring oak processionary caterpillar induced lepidopterism (Part 1): unveiling molecular insights through transcriptomics and proteomics. Cell Mol Life Sci 2024; 81:311. [PMID: 39066932 PMCID: PMC11335235 DOI: 10.1007/s00018-024-05330-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Revised: 05/30/2024] [Accepted: 06/19/2024] [Indexed: 07/30/2024]
Abstract
Lepidopterism, a skin inflammation condition caused by direct or airborne exposure to irritating hairs (setae) from processionary caterpillars, is becoming a significant public health concern. Recent outbreaks of the oak processionary caterpillar (Thaumetopoea processionea) have caused noteworthy health and economic consequences, with a rising frequency expected in the future, exacerbated by global warming promoting the survival of the caterpillar. Current medical treatments focus on symptom relief due to the lack of an effective therapy. While the source is known, understanding the precise causes of symptoms remain incomplete understood. In this study, we employed an advanced method to extract venom from the setae and identify the venom components through high-quality de novo transcriptomics, venom proteomics, and bioinformatic analysis. A total of 171 venom components were identified, including allergens, odorant binding proteins, small peptides, enzymes, enzyme inhibitors, and chitin biosynthesis products, potentially responsible for inflammatory and allergic reactions. This work presents the first comprehensive proteotranscriptomic database of T. processionea, contributing to understanding the complexity of lepidopterism. Furthermore, these findings hold promise for advancing therapeutic approaches to mitigate the global health impact of T. processionea and related caterpillars.
Collapse
Affiliation(s)
- Andrea Seldeslachts
- Toxicology and Pharmacology, Department Pharmaceutical and Pharmacological Sciences, KU Leuven , Leuven, Vlaams-Brabant, Belgium
| | - Marius F Maurstad
- Centre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, Oslo, Norway
| | - Jan Philip Øyen
- Centre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, Oslo, Norway
- Division of biotechnology and plant health & viruses, bacteria and nematodes in forestry, agriculture and horticulture, Norwegian Institute of Bioeconomy Research (NIBIO), Oslo, Norway
| | | | - Steve Peigneur
- Toxicology and Pharmacology, Department Pharmaceutical and Pharmacological Sciences, KU Leuven , Leuven, Vlaams-Brabant, Belgium.
| | - Jan Tytgat
- Toxicology and Pharmacology, Department Pharmaceutical and Pharmacological Sciences, KU Leuven , Leuven, Vlaams-Brabant, Belgium.
| |
Collapse
|
2
|
Midtbø HMD, Eichner C, Hamre LA, Dondrup M, Flesland L, Tysseland KH, Kongshaug H, Borchel A, Skoge RH, Nilsen F, Øvergård AC. Salmon louse labial gland enzymes: implications for host settlement and immune modulation. Front Genet 2024; 14:1303898. [PMID: 38299097 PMCID: PMC10828956 DOI: 10.3389/fgene.2023.1303898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Accepted: 12/18/2023] [Indexed: 02/02/2024] Open
Abstract
Salmon louse (Lepeophtheirus salmonis) is a skin- and blood-feeding ectoparasite, infesting salmonids. While feeding, labial gland proteins from the salmon louse may be deposited on the Atlantic salmon (Salmo salar) skin. Previously characterized labial gland proteins are involved in anti-coagulation and may contribute to inhibiting Atlantic salmon from mounting a sufficient immune response against the ectoparasite. As labial gland proteins seem to be important in the host-parasite interaction, we have, therefore, identified and characterized ten enzymes localized to the labial gland. They are a large group of astacins named L. salmonis labial gland astacin 1-8 (LsLGA 1-8), one serine protease named L. salmonis labial gland serine protease 1 (LsLGSP1), and one apyrase named L. salmonis labial gland apyrase 1 (LsLGAp1). Protein domain predictions showed that LsLGA proteins all have N-terminal ShK domains, which may bind to potassium channels targeting the astacins to its substrate. LsLGA1 and -4 are, in addition, expressed in another gland type, whose secrete also meets the host-parasite interface. This suggests that LsLGA proteins may have an anti-microbial function and may prevent secondary infections in the wounds. LsLGAp1 is predicted to hydrolyze ATP or AMP and is, thereby, suggested to have an immune dampening function. In a knockdown study targeting LsLGSP1, a significant increase in IL-8 and MMP13 at the skin infestation site was seen under LsLGSP1 knockdown salmon louse compared to the control, suggesting that LsLGSP1 may have an anti-inflammatory effect. Moreover, most of the identified labial gland proteins are expressed in mature copepodids prior to host settlement, are not regulated by starvation, and are expressed at similar or higher levels in lice infesting the salmon louse-resistant pink salmon (Oncorhynchus gorbuscha). This study, thereby, emphasizes the importance of labial gland proteins for host settlement and their immune dampening function. This work can further contribute to anti-salmon louse treatment such as vaccine development, functional feed, or gene-edited salmon louse-resistant Atlantic salmon.
Collapse
Affiliation(s)
| | - Christiane Eichner
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | - Lars Are Hamre
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | - Michael Dondrup
- Sea Lice Research Centre, Department of Informatics, University of Bergen, Bergen, Norway
| | - Linn Flesland
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | | | - Heidi Kongshaug
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | - Andreas Borchel
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | - Renate Hvidsten Skoge
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | - Frank Nilsen
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| | - Aina-Cathrine Øvergård
- Sea Lice Research Centre, Department of Biological Sciences, University of Bergen, Bergen, Norway
| |
Collapse
|
3
|
Rodríguez-Banqueri A, Moliner-Culubret M, Mendes SR, Guevara T, Eckhard U, Gomis-Rüth FX. Structural insights into latency of the metallopeptidase ulilysin (lysargiNase) and its unexpected inhibition by a sulfonyl-fluoride inhibitor of serine peptidases. Dalton Trans 2023; 52:3610-3622. [PMID: 36857690 DOI: 10.1039/d3dt00458a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
Abstract
Peptidases are regulated by latency and inhibitors, as well as compatibilization and cofactors. Ulilysin from Methanosarcina acetivorans, also called lysargiNase, is an archaeal metallopeptidase (MP) that is biosynthesized as a zymogen with a 60-residue N-terminal prosegment (PS). In the presence of calcium, it self-activates to yield the mature enzyme, which specifically cleaves before basic residues and thus complements trypsin in proteomics workflows. Here, we obtained a low-resolution crystal structure of proulilysin, in which 28 protomers arranged as 14 dimers form a continuous double helix of 544 Å pitch that parallels cell axis b of the crystal. The PS includes two α-helices and obstructs the active-site cleft of the catalytic domain (CD) by traversing it in the opposite orientation of a substrate, and a cysteine blocks the catalytic zinc according to a "cysteine-switch mechanism". Moreover, the PS interacts through its first helix with an "S-loop" of the CD, which acts as an "activation segment" that lacks one of two essential calcium cations. Upon PS removal during maturation, the S-loop adopts its competent conformation and binds the second calcium ion. Next, we found that in addition to general MP inhibitors, ulilysin was competitively and reversibly inhibited by 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF; Ki = 4 μM). This is a compound that normally forms an irreversible covalent complex with serine peptidases but does not inhibit MPs. A high-resolution crystal structure of the complex revealed that the inhibitor penetrates the specificity pocket of ulilysin. A primary amine of the inhibitor salt-bridges an aspartate at the pocket bottom, thus mimicking the basic side chain of substrates. In contrast, the sulfonyl fluoride warhead is not involved and the catalytic zinc ion is freely accessible. Thus, the usage of inhibitor cocktails of peptidases, which typically contain AEBSF at ∼25-fold higher concentrations than the determined Ki, should be avoided when working with ulilysin. Finally, the structure of the complex, which occurred as a crystallographic dimer recurring in previous mature ulilysin structures, unveiled an N-terminal product fragment that delineated the non-primed side of the cleft. These results complement prior structures of ulilysin with primed-side product fragments and inhibitors.
Collapse
Affiliation(s)
- Arturo Rodríguez-Banqueri
- Proteolysis Laboratory; Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Higher Scientific Research Council (CSIC); Barcelona Science Park; c/Baldiri Reixac 4-8, Tower R, 08028 Barcelona, Catalonia, Spain.
| | - Marina Moliner-Culubret
- Proteolysis Laboratory; Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Higher Scientific Research Council (CSIC); Barcelona Science Park; c/Baldiri Reixac 4-8, Tower R, 08028 Barcelona, Catalonia, Spain.
| | - Soraia R Mendes
- Proteolysis Laboratory; Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Higher Scientific Research Council (CSIC); Barcelona Science Park; c/Baldiri Reixac 4-8, Tower R, 08028 Barcelona, Catalonia, Spain.
| | - Tibisay Guevara
- Proteolysis Laboratory; Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Higher Scientific Research Council (CSIC); Barcelona Science Park; c/Baldiri Reixac 4-8, Tower R, 08028 Barcelona, Catalonia, Spain.
| | - Ulrich Eckhard
- Proteolysis Laboratory; Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Higher Scientific Research Council (CSIC); Barcelona Science Park; c/Baldiri Reixac 4-8, Tower R, 08028 Barcelona, Catalonia, Spain.
| | - F Xavier Gomis-Rüth
- Proteolysis Laboratory; Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Higher Scientific Research Council (CSIC); Barcelona Science Park; c/Baldiri Reixac 4-8, Tower R, 08028 Barcelona, Catalonia, Spain.
| |
Collapse
|